Long-term medicine storage device based on cold chain management

By collecting cold chain equipment and drug information in real time, combining drug ingredient deposition analysis and shaking control optimization, and optimizing refrigeration temperature control, the problems of deposition and degradation of medicines in cold chain transportation are solved, ensuring the long-term storage quality of drugs.

CN118941192AInactive Publication Date: 2024-11-12KEYPOINT PHARM TECH (QIDONG) CO LTD

Patent Information

Application Number
CN202411428268.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-14
Publication Date
2024-11-12
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

During cold chain transportation, the ingredients of medicines are prone to deposition and deterioration, making it difficult to preserve for a long time.

Method used

By collecting the refrigeration temperature of cold chain equipment, drug ingredient information and driving characteristic data during transportation in real time, combining drug ingredient deposition analysis and shaking control optimization, the optimal shaking control parameters and temperature change influence parameters are obtained, and the refrigeration temperature control scheme is optimized. Reduce drug deposition and deterioration.

Benefits of technology

Effectively reduce the deposition and deterioration of drugs during transportation and ensure the quality and effectiveness of drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118941192A_ABST
    Figure CN118941192A_ABST
Patent Text Reader

Abstract

The invention discloses a medicine long-term storage device based on cold chain management, and relates to the related field of data processing, and the device comprises the steps: collecting the refrigeration temperature of cold chain equipment and the medicine component information of refrigerated transportation medicines; and performing medicine component deposition analysis to obtain medicine component deposition information. Driving characteristic data recorded in cold chain transportation are collected, medicine shaking deposition elimination optimization is carried out in combination with medicine component deposition information, and optimal shaking control parameters are obtained; according to the optimal shaking control parameters, shaking equipment is controlled to carry out shaking deposition elimination, shaking temperature change influence analysis of the shaking equipment is carried out, and temperature change influence parameters are obtained; and according to the temperature change influence parameters, refrigeration temperature control optimization is carried out, an optimal refrigeration temperature control scheme is obtained, refrigeration temperature control is carried out on cold chain equipment, and cold chain transportation long-term preservation of medicines is carried out. The technical problems that in the prior art, medicine components are prone to deposition and degradation in the cold chain transportation process, and medicine is difficult to store for a long time are solved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to data processing related fields, and in particular to a long-term storage device for medicines based on cold chain management. Background Art

[0002] With the rapid development of the modern pharmaceutical industry, the quality and preservation of drugs have become increasingly important. Especially for certain drugs that need to be stored at low temperatures, such as vaccines and biological agents, cold chain transportation plays a key role in the entire supply chain. During cold chain transportation, the storage state of drugs will be affected by various factors such as temperature fluctuations and transportation bumps, which can easily lead to the deposition and deterioration of drug components. Therefore, how to maintain the stability and effectiveness of drugs during cold chain transportation has become a technical problem that needs to be solved urgently.

[0003] Therefore, in the prior art, the cold chain transportation process easily leads to the deposition and deterioration of drug ingredients, making it difficult to preserve the drugs for a long time. Summary of the invention

[0004] This application solves the technical problem in the prior art that the cold chain transportation process easily leads to the deposition and deterioration of drug components, and the drugs are difficult to preserve for a long time by providing a long-term drug storage device based on cold chain management. By real-time collection of the cold chain equipment's refrigeration temperature, drug component information, and driving characteristic data during transportation, combined with drug component deposition analysis and sway control optimization, the optimal sway control parameters and temperature change influencing parameters are obtained, and finally by optimizing the refrigeration temperature control scheme, the deposition and deterioration of drugs during transportation are effectively reduced, ensuring the quality and effectiveness of drugs.

[0005] The present application provides a long-term storage device for medicines based on cold chain management, the device includes cold chain equipment and shaking equipment, and the device also includes: a data acquisition module, used to collect the refrigeration temperature of the cold chain equipment in the current cold chain transportation, and the drug component information of the refrigerated transportation drugs; a deposition analysis module, used to combine the refrigeration temperature and the drug component information, perform drug component deposition analysis, and obtain drug component deposition information; a sway control parameter acquisition module, used to collect the driving characteristic data recorded in the cold chain transportation, and optimize the elimination of drug sway deposition in combination with the drug component deposition information to obtain optimal sway control parameters; a temperature change influence analysis module, used to control the sway device to eliminate sway deposition of refrigerated transportation drugs according to the optimal sway control parameters, and perform sway temperature change influence analysis of the sway device to obtain temperature change influence parameters; a temperature control module, used to optimize the refrigeration temperature control of the cold chain equipment according to the temperature change influence parameters, obtain the optimal refrigeration temperature control plan, perform refrigeration temperature control on the cold chain equipment, and perform cold chain transportation long-term storage of drugs.

[0006] In a possible implementation, the deposition analysis module is also used to: collect a sample refrigeration temperature set and a sample drug component information set based on the refrigeration data records of the cold chain equipment, and obtain a sample drug component deposition information set based on the deposition test data of drugs with different sample drug component information at different sample refrigeration temperatures; use the sample refrigeration temperature set, sample drug component information set and sample drug component deposition information set to train a drug deposition predictor; use the drug deposition predictor to perform drug component deposition analysis on the refrigeration temperature and drug component information to obtain drug component deposition information.

[0007] In a possible implementation, the sway control parameter acquisition module is further used to: construct a drug sway optimization function based on minimizing drug component deposition information, as shown in the following formula: ; Among them, ODS is the shaking fitness, and is the weight, K is the deposition information of the drug components after shaking according to the shaking control parameters, e is the natural logarithm, and P is the shaking power of the shaking control parameters; according to the drug shaking optimization function, the drug shaking deposition elimination is optimized according to the drug component deposition information to obtain the optimized shaking control parameters; the driving characteristic data recorded in the cold chain transportation is collected, and according to the driving characteristic data, the optimized shaking control parameters are compensated and adjusted to obtain the optimal shaking control parameters, wherein the driving characteristic data includes the driving bumpiness in the cold chain transportation.

[0008] In a possible implementation, the sway control parameter acquisition module is also used to: acquire the sway control parameter space of the sway device, randomly generate a first sway control parameter in the sway control parameter space, wherein the sway control parameter includes a sway amplitude and a sway frequency; perform sway deposition elimination prediction according to the drug component deposition information and the drug component information, in combination with the first sway control parameter, to obtain the first drug component deposition information, wherein a sample drug component deposition information set, a sample drug component information set and a sample sway control parameter set are collected, and a sway deposition elimination predictor is trained for prediction; based on the drug sway optimization function, a first sway power of the first sway control parameter is acquired, and a first sway fitness is calculated in combination with the first drug component deposition information; the optimization is continued until the iteration requirements are met, and the sway control parameter with the largest sway fitness is output to obtain the optimized sway control parameter.

[0009] In a possible implementation, the sway control parameter acquisition module is also used to: collect the riding bumps at multiple time nodes recorded in the cold chain transportation, calculate the average riding bumps as the riding characteristic data; and compensate and adjust the optimized sway amplitude and optimized sway frequency in the optimized sway control parameters according to the turbulence amplitude and turbulence frequency in the driving characteristic data to obtain the optimal sway amplitude and optimal sway frequency as the optimal sway control parameters.

[0010] In a possible implementation, the temperature change impact analysis module is also used to: control the shaking device to eliminate shaking deposits on refrigerated transported medicines according to the optimal shaking control parameters; collect a sample shaking control parameter set, a sample shaking power set and a sample refrigerated temperature set, and collect a sample power temperature change impact parameter set and a sample shaking temperature change impact parameter set, wherein the sample power temperature change impact parameter includes the impact parameter of the shaking power on the medicine temperature, and the sample shaking temperature change impact includes the impact parameter of the shaking on the medicine temperature; use the sample shaking control parameter set and the sample refrigerated temperature set and a set of sample sway temperature change influencing parameters, train a sway temperature change influencing analysis branch, adopt the sample sway power set, the sample refrigeration temperature set and the sample power temperature change influencing parameter set to train a power temperature change influencing analysis branch; integrate the sway temperature change influencing analysis branch and the power temperature change influencing analysis branch to obtain a temperature change stress analyzer; obtain the optimal sway power of the optimal sway control parameters, adopt the temperature change stress analyzer to perform temperature change stress analysis on the optimal sway control parameters and the optimal sway power, obtain sway temperature change influencing parameters and power temperature change influencing parameters, and calculate to obtain the temperature change influencing parameters.

[0011] In a possible implementation, the temperature control module is also used to: randomly select a first refrigeration temperature control scheme in the refrigeration temperature control scheme space of the cold chain equipment; obtain the first refrigeration temperature under the control of the first refrigeration temperature control scheme, and calculate the first changed drug refrigeration temperature in combination with the temperature change influencing parameter; calculate the first temperature control fitness according to the deviation between the first changed drug refrigeration temperature and the refrigeration temperature; continue to optimize the refrigeration temperature control, and obtain the refrigeration temperature control scheme with the maximum temperature control fitness as the optimal refrigeration temperature control scheme. The shaking device is a drug shaking device.

[0012] One or more technical solutions provided in this application have at least the following technical effects or advantages: The long-term storage device for medicines based on cold chain management provided by the present application includes: a data acquisition module, which is used to collect the refrigeration temperature of the cold chain equipment in the current cold chain transportation, and the drug component information of the refrigerated transportation medicine; a deposition analysis module, which is used to combine the refrigeration temperature and the drug component information to perform drug component deposition analysis and obtain drug component deposition information; a sway control parameter acquisition module, which is used to collect the driving characteristic data recorded in the cold chain transportation, and optimize the elimination of drug sway deposition in combination with the drug component deposition information to obtain the optimal sway control parameters; a temperature change impact analysis module, which is used to control the sway device to eliminate sway deposition of refrigerated transportation medicines according to the optimal sway control parameters, and perform sway temperature change impact analysis of the sway device to obtain temperature change impact parameters; a temperature control module, which is used to optimize the refrigeration temperature control of the cold chain equipment according to the temperature change impact parameters, obtain the optimal refrigeration temperature control scheme, perform refrigeration temperature control on the cold chain equipment, and perform long-term cold chain transportation of medicines. The technical problem that the cold chain transportation process in the prior art easily leads to the deposition and deterioration of drug components and the difficulty of long-term preservation of drugs is solved. By real-time collection of cold chain equipment's refrigeration temperature, drug ingredient information, and driving characteristics data during transportation, combined with drug ingredient deposition analysis and slosh control optimization, the optimal slosh control parameters and temperature change influencing parameters are obtained. Ultimately, by optimizing the refrigeration temperature control solution, the deposition and deterioration of drugs during transportation are effectively reduced, ensuring the quality and effectiveness of drugs. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] In order to more clearly illustrate the technical solution of the embodiment of the present invention, the accompanying drawings of the embodiment of the present invention will be briefly introduced below. A flow chart is used in the present application to illustrate the operations performed by the device according to the embodiment of the present application. It should be understood that the previous or following operations are not necessarily performed accurately in order. On the contrary, various steps can be processed in reverse order or simultaneously as needed. At the same time, other operations can also be added to these processes, or one or more operations can be removed from these processes.

[0014] Figure 1 A schematic diagram of the structure of a long-term drug storage device based on cold chain management provided in an embodiment of the present application; Figure 2 This is a schematic diagram of the process of obtaining drug component deposition information by a deposition analysis module in a drug long-term storage device based on cold chain management in this application.

[0015] Explanation of reference numerals: data acquisition module 11 , deposition analysis module 12 , sway control parameter acquisition module 13 , temperature change influence analysis module 14 , temperature control module 15 . DETAILED DESCRIPTION

[0016] The above description is only an overview of the technical solution of the present application. In order to more clearly understand the technical means of the present application, it can be implemented in accordance with the contents of the specification. In order to make the above and other purposes, features and advantages of the present application more obvious and easy to understand, the specific implementation methods of the present application are listed below.

[0017] In order to make the purpose, technical solutions and advantages of the present application clearer, the present application will be further described in detail below in conjunction with the accompanying drawings. The described embodiments should not be regarded as limiting the present application. All other embodiments obtained by ordinary technicians in the field without making creative work are within the scope of protection of this application.

[0018] In the following description, reference is made to "some embodiments", which describe a subset of all possible embodiments, but it is understood that "some embodiments" may be the same subset or different subsets of all possible embodiments, and may be combined with each other without conflict, and the terms "first\second" involved are merely to distinguish similar objects and do not represent a specific ordering of objects. The terms "including" and "having" and any variations are intended to cover non-exclusive inclusions, for example, a process, device, product, or server that includes a series of steps or units is not necessarily limited to those steps or units that are clearly listed, but may include other steps or modules that are not clearly listed or inherent to these processes, devices, products, or equipment. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by technicians in the technical field of this application. The terms used herein are for the purpose of describing the embodiments of the present application only.

[0019] The present application embodiment provides a long-term storage device for medicines based on cold chain management, such as Figure 1 As shown, the device comprises: A data collection module is used to collect the refrigeration temperature of the cold chain equipment in the current cold chain transportation, and the drug ingredient information of the refrigerated transportation drugs; A deposition analysis module, used to perform drug component deposition analysis in combination with the refrigeration temperature and drug component information to obtain drug component deposition information; A sloshing control parameter acquisition module is used to collect the driving characteristic data recorded in the cold chain transportation, and optimize the elimination of drug sloshing and deposition in combination with the drug component deposition information to obtain the optimal sloshing control parameters; The long-term storage device for cold chain management includes cold chain equipment and shaking equipment. The cold chain equipment is refrigeration equipment such as a refrigeration box, etc. The shaking equipment is a drug shaking device, such as an oscillator, a centrifuge, a rotary mixer, etc. The refrigeration temperature of the cold chain equipment during the current cold chain transportation is collected by a sensor, and the refrigeration temperature is the actual refrigeration temperature of the drug. The sensor must have the characteristics of high precision and fast response to ensure the real-time accuracy of the temperature data. The drug component information of the refrigerated transportation drug is collected through a database or by directly inputting the drug component information. The component information includes the active ingredients of the drug and its physical and chemical properties, such as solubility, melting point, etc. Further, combined with the refrigeration temperature and drug component information, the drug component deposition analysis is performed to obtain the drug component deposition information. Subsequently, the driving characteristic data recorded in the cold chain transportation is collected. The driving characteristic data is collected by an acceleration sensor installed on the transport vehicle to obtain the bump amplitude and bump frequency of the vehicle during transportation. The bump amplitude and bump frequency at multiple time nodes are averaged to obtain the driving characteristic data. Combined with the drug component deposition information, the drug sloshing and deposition elimination optimization is performed to obtain the optimal sloshing control parameter. The optimal sloshing control parameter is the optimal control parameter for eliminating drug deposition by the sloshing device under the condition of considering the jolt amplitude and jolt frequency during transportation.

[0020] Further, such as Figure 2 As shown, the deposition analysis module 12 is also used for: collecting a sample refrigeration temperature set and a sample drug component information set according to the refrigeration data records of the cold chain equipment, and obtaining a sample drug component deposition information set according to the deposition test data of drugs with different sample drug component information at different sample refrigeration temperatures; using the sample refrigeration temperature set, the sample drug component information set and the sample drug component deposition information set to train a drug deposition predictor; using the drug deposition predictor to perform drug component deposition analysis on the refrigeration temperature and drug component information to obtain drug component deposition information.

[0021] Combined with the refrigeration temperature and drug component information, drug component deposition analysis is performed to obtain drug component deposition information, including: collecting refrigeration temperature data under different time periods and different conditions through the refrigeration data record of the cold chain equipment, the refrigeration data record of the cold chain equipment contains refrigeration temperature records and corresponding drug component records. These data will form a sample refrigeration temperature set. For example, 100 groups of refrigeration temperature data are randomly selected from multiple cold chain transportations to form a diverse temperature sample set. Subsequently, the component information of the corresponding refrigerated multiple drugs is extracted, including its main active ingredients, excipient ingredients and their physical and chemical properties. These data will form a sample drug component information set. For example, the component information of 10 different drugs is collected, and the component information of each drug includes specific ingredients, melting point, solubility, etc. According to the deposition test data of drugs with different sample drug component information at different sample refrigeration temperatures, a sample drug component deposition information set is obtained. For different sample drugs, deposition test experiments are carried out under different sample refrigeration temperature conditions to record the deposition of drugs at various temperatures. For example, sample drug A is placed in a cold storage environment at 0°C, 5°C, and 10°C for a week, respectively. The deposition conditions are recorded every day, and the experimental results are sorted to form the deposition information of the sample drug components. The deposition tests of different sample drugs at different cold storage temperatures are completed to obtain a set of deposition information of the sample drug components.

[0022] The sample refrigeration temperature set, the sample drug component information set and the sample drug component deposition information set are preprocessed to ensure the consistency and integrity of the data. The preprocessed sample refrigeration temperature set, the sample drug component information set and the sample drug component deposition information set are used as training data, and supervised training of the drug deposition predictor is performed based on the random forest algorithm. During the model training process, the model parameters are optimized using the cross-validation method to ensure the generalization ability of the model until the output result of the model meets the preset accuracy rate to obtain the drug deposition predictor. Finally, the drug deposition predictor is used to perform drug component deposition analysis on the refrigeration temperature and drug component information to obtain the drug component deposition information of the drug component information at the refrigeration temperature.

[0023] Furthermore, the sway control parameter acquisition module 13 is also used to construct a drug sway optimization function based on minimizing drug component deposition information, as shown in the following formula: ; Among them, ODS is the shaking fitness, and is the weight, K is the deposition information of the drug components after shaking according to the shaking control parameters, e is the natural logarithm, and P is the shaking power of the shaking control parameters; according to the drug shaking optimization function, the drug shaking deposition elimination is optimized according to the drug component deposition information to obtain the optimized shaking control parameters; the driving characteristic data recorded in the cold chain transportation is collected, and according to the driving characteristic data, the optimized shaking control parameters are compensated and adjusted to obtain the optimal shaking control parameters, wherein the driving characteristic data includes the driving bumpiness in the cold chain transportation.

[0024] The driving characteristic data recorded in the cold chain transportation are collected, and the drug sloshing deposition elimination optimization is performed in combination with the drug component deposition information to obtain the optimal sloshing control parameters, including: based on minimizing the drug component deposition information, constructing a drug sloshing optimization function, as shown in the following formula: Wherein, ODS is the sloshing fitness, and is a weight parameter pre-set according to actual preference. For example, the preference is that the less the deposition of drug components, the corresponding The higher the weight, K is the deposition information of the drug components after shaking according to the shaking control parameters, and the smaller K is, the less the deposition of the drug components after shaking control. e is the natural logarithm, and P is the shaking power of the shaking control parameter. According to the drug shaking optimization function, the drug shaking deposition elimination is optimized according to the drug component deposition information to obtain the optimized shaking control parameters. Further, the driving characteristic data recorded in the cold chain transportation is collected, and the optimized shaking control parameters are compensated and adjusted according to the driving characteristic data to obtain the optimal shaking control parameters, wherein the driving characteristic data includes the driving bumpiness in the cold chain transportation.

[0025] Furthermore, the sway control parameter acquisition module 13 is also used to: acquire the sway control parameter space of the sway device, randomly generate a first sway control parameter in the sway control parameter space, wherein the sway control parameter includes sway amplitude and sway frequency; perform sway deposition elimination prediction according to the drug component deposition information and the drug component information, in combination with the first sway control parameter, to obtain first drug component deposition information, wherein a sample drug component deposition information set, a sample drug component information set and a sample sway control parameter set are collected, and a sway deposition elimination predictor is trained for prediction; based on the drug sway optimization function, a first sway power of the first sway control parameter is acquired, and a first sway fitness is calculated in combination with the first drug component deposition information; the optimization is continued until the iteration requirements are met, and the sway control parameter with the largest sway fitness is output to obtain the optimized sway control parameter.

[0026] Determine the sway control parameter space of the sway device, and the sway control parameters include sway control parameters such as sway amplitude and sway frequency. The sway control parameter space is the specific parameter control interval of each sway control parameter of the device. Subsequently, each control parameter is randomly extracted in the sway control parameter space to generate a first sway control parameter. Further, according to the drug component deposition information and the drug component information, combined with the first sway control parameter, sway deposition elimination prediction is performed to obtain the first drug component deposition information, and the first drug component deposition information is the residual component deposition information after sway elimination. Among them, the sample drug component deposition information set, the sample drug component information set and the sample sway control parameter set are collected, and the sway deposition elimination predictor is trained for prediction. The sample drug component information set includes various types of sample drug component information data and initial drug component deposition information. The sample sway control parameter set includes the specific control data of each corresponding sway control parameter. The sample drug component deposition information set is the residual drug component deposition information obtained after the elements in the sample drug component information set are controlled by the corresponding sample sway control parameters. The sample drug component deposition information set, the sample drug component information set and the sample sway control parameter set are used as training data to supervise the neural network model until the output accuracy of the model meets the threshold, and the trained model is obtained to obtain the sway deposition elimination prediction model. The sway deposition elimination prediction model is used to predict the sway deposition elimination according to the drug component deposition information and the drug component information and the specific sway control parameters to obtain the predicted sample drug component deposition information.

[0027] Based on the drug sway optimization function, the first sway power of the first sway control parameter is obtained, and the first sway power is the equipment operating power corresponding to the first sway control parameter. The first sway power obtained and the first drug component deposition information are input into the drug sway optimization function to calculate the fitness and obtain the first sway fitness. The random sway control parameters are continuously obtained, and the sway deposition elimination prediction is performed to obtain the sway fitness, and the sway control parameter with the largest sway fitness is retained, and the iteration is continued until the iteration requirement is met. The iteration requirement is to output the sway control parameter with the largest sway fitness when the preset number of iterations is met or the sway fitness reaches the preset threshold, and obtain the optimized sway control parameter corresponding to the largest sway control parameter.

[0028] Furthermore, the sway control parameter acquisition module 13 is also used to: collect the driving bumps at multiple time nodes recorded in the cold chain transportation, calculate the average driving bumps as driving characteristic data; and compensate and adjust the optimized sway amplitude and optimized sway frequency in the optimized sway control parameters according to the turbulence amplitude and turbulence frequency in the driving characteristic data to obtain the optimal sway amplitude and optimal sway frequency as the optimal sway control parameters.

[0029] During the cold chain transportation process, the acceleration sensor installed on the transport vehicle is used to collect the driving bumpiness data of multiple time nodes in real time. The driving bumpiness data includes the bumping amplitude and bumping frequency of the vehicle. The average driving bumpiness of multiple time nodes is calculated as the driving characteristic data, and the driving characteristic data includes the bumping amplitude and bumping frequency. According to the bumping amplitude and bumping frequency in the driving characteristic data, the optimized sway amplitude and optimized sway frequency in the optimized sway control parameters are compensated and adjusted to obtain the optimal sway amplitude and optimal sway frequency as the optimal sway control parameters. When making compensation adjustments, a compensation algorithm is set, and the bumping amplitude and bumping frequency in the original optimized sway control parameters are compensated and adjusted according to the bumping amplitude and bumping frequency in the driving characteristic data. The bumping during vehicle driving will have a positive impact on the swaying process of the swaying device. The compensation coefficient is set by professional and technical personnel based on the impact size, and the compensation coefficient is used to compensate the driving characteristic data to the sway control parameters in proportion, so as to obtain the optimal sway control parameters. The optimal sway amplitude is the optimized sway amplitude minus the jolt amplitude compensation, and the optimal sway frequency is the optimized sway frequency minus the jolt frequency compensation. The jolt amplitude compensation is the average jolt amplitude multiplied by the compensation coefficient, and the jolt frequency compensation is the average jolt frequency multiplied by the compensation coefficient. The optimal sway amplitude and optimal sway frequency are obtained as the optimal sway control parameters.

[0030] The temperature change impact analysis module is used to control the shaking device to eliminate shaking deposits on refrigerated transported medicines according to the optimal shaking control parameters, and to analyze the shaking temperature change impact of the shaking device to obtain temperature change impact parameters; the temperature control module is used to optimize the refrigerated temperature control of the cold chain equipment according to the temperature change impact parameters, obtain the optimal refrigerated temperature control plan, control the refrigerated temperature of the cold chain equipment, and carry out long-term storage of medicines through cold chain transportation.

[0031] According to the optimal sloshing control parameters, the sloshing device is controlled to eliminate sloshing deposition of refrigerated transported medicines. The sloshing temperature change influence analysis of the sloshing device is performed to obtain the temperature change influence parameters. Since the sloshing device generates heat when it is sloshing, and the sloshing friction also physically generates heat, it will affect the refrigerated temperature of the medicine, causing the temperature to rise, thereby affecting the storage. According to the temperature change influence parameters obtained by the analysis, the refrigerated temperature control optimization of the cold chain equipment is performed to obtain the optimal refrigerated temperature control scheme, and the refrigerated temperature of the cold chain equipment is controlled to perform long-term cold chain transportation of medicines. The technical problem that the cold chain transportation process in the prior art is prone to cause the deposition and deterioration of the drug components and the drugs are difficult to preserve for a long time is solved. By real-time collection of the refrigerated temperature of the cold chain equipment, the drug component information and the driving characteristic data during the transportation process, combined with the drug component deposition analysis and sloshing control optimization, the optimal sloshing control parameters and temperature change influence parameters are obtained, and finally by optimizing the refrigerated temperature control scheme, the deposition and deterioration of the drugs during the transportation process are effectively reduced to ensure the quality and effectiveness of the drugs.

[0032] Furthermore, the temperature change impact analysis module 14 is also used to: control the shaking device to eliminate shaking deposition of refrigerated transported medicines according to the optimal shaking control parameters; collect a sample shaking control parameter set, a sample shaking power set and a sample refrigerated temperature set, and collect a sample power temperature change impact parameter set and a sample shaking temperature change impact parameter set, wherein the sample power temperature change impact parameter includes the impact parameter of the shaking power on the medicine temperature, and the sample shaking temperature change impact includes the impact parameter of the shaking on the medicine temperature; use the sample shaking control parameter set, the sample refrigerated temperature set and A set of sample sway temperature change influence parameters is used to train a sway temperature change influence analysis branch. The sample sway power set, the sample refrigeration temperature set and the sample power temperature change influence parameter set are used to train a power temperature change influence analysis branch. The sway temperature change influence analysis branch and the power temperature change influence analysis branch are integrated to obtain a temperature change stress analyzer. The optimal sway power of the optimal sway control parameters is obtained. The temperature change stress analyzer is used to perform a temperature change stress analysis on the optimal sway control parameters and the optimal sway power to obtain sway temperature change influence parameters and power temperature change influence parameters, and the temperature change influence parameters are calculated.

[0033] According to the determined optimal shaking control parameters, the shaking equipment is controlled to work to eliminate the deposition of refrigerated transported medicines. Subsequently, sample data is collected, that is, a sample shaking control parameter set, a sample shaking power set and a sample refrigerated temperature set are collected, and a sample power temperature change influence parameter set and a sample shaking temperature change influence parameter set are collected, wherein the sample power temperature change influence parameter includes the influence parameter of the shaking power on the medicine temperature, and the sample shaking temperature change influence includes the influence parameter of the shaking on the medicine temperature. The sample shaking control parameter set is a control parameter combination of different shaking amplitudes and frequencies. The sample shaking power set is the power consumption data under different shaking parameters. The sample refrigerated temperature set is the refrigerated temperature data under different shaking parameters. The sample power temperature change influence parameter set is the influence data of the power corresponding to the shaking parameter on the medicine temperature. The sample shaking temperature change influence parameter set is the influence data of the shaking operation corresponding to the shaking parameter on the medicine temperature. Further, the sample sway control parameter set, the sample refrigeration temperature set and the sample sway temperature change influence parameter set are used to train the sway temperature change influence analysis branch, and the sample sway power set, the sample refrigeration temperature set and the sample power temperature change influence parameter set are used to train the power temperature change influence analysis branch, wherein both the sway temperature change influence analysis branch and the power temperature change influence analysis branch are constructed through a neural network model. The sample sway control parameter set, the sample refrigeration temperature set and the sample sway temperature change influence parameter set are used to train the model to predict the impact of sway on the temperature of the drug. Power temperature change influence analysis branch: The sample sway power set, the sample refrigeration temperature set and the sample power temperature change influence parameter set are used to train the model to predict the impact of power on the temperature of the drug. The trained sway temperature change influence analysis branch and the power temperature change influence analysis branch are integrated to form a temperature change response analyzer. The analyzer comprehensively considers the impact of sway and power on the temperature of the drug, adds the temperature results output by the analysis branch, and obtains an accurate prediction of the temperature change impact. Finally, the optimal sway power of the optimal sway control parameter is obtained, and the temperature-dependent stress analyzer is used to perform temperature-dependent stress analysis on the optimal sway control parameter and the optimal sway power to obtain sway temperature-dependent stress influence parameters and power temperature-dependent stress influence parameters, which are then added together to obtain the temperature-dependent stress influence parameters.

[0034] Furthermore, the temperature control module 15 is also used to: randomly select a first refrigeration temperature control scheme in the refrigeration temperature control scheme space of the cold chain equipment; obtain the first refrigeration temperature under the control of the first refrigeration temperature control scheme, and calculate the first changed drug refrigeration temperature in combination with the temperature change influencing parameters; calculate the first temperature control fitness based on the deviation between the first changed drug refrigeration temperature and the refrigeration temperature; continue to optimize the refrigeration temperature control, and obtain the refrigeration temperature control scheme with the largest temperature control fitness as the optimal refrigeration temperature control scheme.

[0035] According to the temperature change influencing parameter, the cold storage temperature control of the cold chain equipment is optimized to obtain the optimal cold storage temperature control scheme, including: randomly selecting a first cold storage temperature control scheme in the cold storage temperature control scheme space of the cold chain equipment, and the first cold storage temperature control scheme is used to control the temperature to reach the first cold storage temperature. Obtain the first cold storage temperature under the control of the first cold storage temperature control scheme, and calculate the first changed drug cold storage temperature in combination with the temperature change influencing parameter. For example, if the standard cold storage temperature of the drug is -10°C, the first cold storage temperature is -12°C, and the temperature change influencing parameter is a rise of 1°C, then the first changed drug cold storage temperature is -11°C, and the deviation is 1. The smaller the deviation, the greater the fitness. The fitness calculation formula is 10 divided by the temperature deviation parameter. The temperature deviation parameter is the difference between the absolute value of the standard cold storage temperature and the first changed drug cold storage temperature. Continue to obtain the cold storage control temperature, calculate the temperature deviation parameter, obtain the temperature control fitness, and continuously iterate and optimize to obtain the cold storage temperature control scheme with the largest temperature control fitness as the optimal cold storage temperature control scheme.

[0036] The embodiment of the present application collects the refrigeration temperature of the cold chain equipment and the drug component information of the refrigerated transported drugs. Perform drug component deposition analysis to obtain drug component deposition information. Collect the driving characteristic data recorded in the cold chain transportation, combine the drug component deposition information to optimize the drug sloshing deposition elimination, and obtain the optimal sloshing control parameters; according to the optimal sloshing control parameters, control the sloshing equipment to eliminate sloshing deposition, and analyze the sloshing temperature change influence of the sloshing equipment to obtain the temperature change influence parameters; according to the temperature change influence parameters, optimize the refrigeration temperature control, obtain the optimal refrigeration temperature control scheme, control the refrigeration temperature of the cold chain equipment, and carry out long-term storage of the cold chain transportation of drugs. It solves the technical problem that the cold chain transportation process in the prior art is prone to cause the deposition and deterioration of drug components, and the drugs are difficult to preserve for a long time. By real-time collection of the refrigeration temperature of the cold chain equipment, drug component information and driving characteristic data during transportation, combined with drug component deposition analysis and sloshing control optimization, the optimal sloshing control parameters and temperature change influence parameters are obtained, and finally by optimizing the refrigeration temperature control scheme, the deposition and deterioration of drugs during transportation are effectively reduced to ensure the quality and effectiveness of drugs.

[0037] The above specific implementation manner does not constitute a limitation to the protection scope of the present application. It should be understood by those skilled in the art that various modifications, combinations and substitutions can be made according to design requirements and other factors. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present application should be included in the protection scope of the present application. In some cases, the actions or steps recorded in the present application can be performed in an order different from that in the embodiment and can still achieve the desired results. In addition, the process depicted in the accompanying drawings does not necessarily require the specific order or continuous order shown to achieve the desired results. In some embodiments, multitasking and parallel processing are also possible or may be advantageous.

Claims

1. A long-term drug storage device based on cold chain management, characterized in that: The device comprises a cold chain device and a shaking device, and the device further comprises: A data collection module is used to collect the refrigeration temperature of the cold chain equipment in the current cold chain transportation, and the drug ingredient information of the refrigerated transportation drugs; A deposition analysis module, used to perform drug component deposition analysis in combination with the refrigeration temperature and drug component information to obtain drug component deposition information; A sloshing control parameter acquisition module is used to collect the driving characteristic data recorded in the cold chain transportation, and optimize the elimination of drug sloshing and deposition in combination with the drug component deposition information to obtain the optimal sloshing control parameters; A temperature change impact analysis module, used to control the shaking device to eliminate shaking deposits of refrigerated transport medicines according to the optimal shaking control parameters, and to analyze the shaking temperature change impact of the shaking device to obtain temperature change impact parameters; The temperature control module is used to optimize the refrigeration temperature control of the cold chain equipment according to the temperature change influencing parameters, obtain the optimal refrigeration temperature control plan, control the refrigeration temperature of the cold chain equipment, and carry out cold chain transportation and long-term storage of medicines.

2. The drug long-term storage device based on cold chain management according to claim 1, characterized in that: The deposition analysis module is also used for: According to the cold storage data records of the cold chain equipment, a sample cold storage temperature set and a sample drug component information set are collected, and according to the deposition test data of drugs with different sample drug component information at different sample cold storage temperatures, a sample drug component deposition information set is obtained; Using the sample refrigeration temperature set, the sample drug component information set and the sample drug component deposition information set to train a drug deposition predictor; The drug deposition predictor is used to perform drug component deposition analysis on the refrigeration temperature and drug component information to obtain drug component deposition information.

3. The drug long-term storage device based on cold chain management according to claim 1, characterized in that: The sway control parameter acquisition module is also used for: Based on minimizing the deposition information of drug components, a drug shaking optimization function is constructed as follows: ; Among them, ODS is the shaking fitness, and is the weight, K is the deposition information of the drug components after shaking according to the shaking control parameters, e is the natural logarithm, and P is the shaking power of the shaking control parameters; According to the drug sloshing optimization function, the drug sloshing deposition elimination optimization is performed according to the drug component deposition information to obtain optimized sloshing control parameters; Driving characteristic data recorded in cold chain transportation are collected, and according to the driving characteristic data, the optimized sway control parameters are compensated and adjusted to obtain optimal sway control parameters, wherein the driving characteristic data includes the driving bumpiness in cold chain transportation.

4. The drug long-term storage device based on cold chain management according to claim 3 is characterized in that: The sway control parameter acquisition module is also used for: Acquire a sway control parameter space of the sway device, and randomly generate a first sway control parameter in the sway control parameter space, wherein the sway control parameter includes a sway amplitude and a sway frequency; According to the drug component deposition information and the drug component information, combined with the first sloshing control parameter, a sloshing deposition elimination prediction is performed to obtain the first drug component deposition information, wherein a sample drug component deposition information set, a sample drug component information set and a sample sloshing control parameter set are collected, and a sloshing deposition elimination predictor is trained to perform prediction; Based on the drug sway optimization function, a first sway power of the first sway control parameter is obtained, and a first sway fitness is calculated and obtained in combination with the first drug component deposition information; The optimization is continued until the iteration requirement is met, and the sway control parameter with the maximum sway adaptability is output to obtain the optimized sway control parameter.

5. The drug long-term storage device based on cold chain management according to claim 3, characterized in that: The sway control parameter acquisition module is also used for: Collect the driving bumpiness at multiple time points in the cold chain transportation records, and calculate the average driving bumpiness as driving characteristic data; According to the jolting amplitude and jolting frequency in the driving characteristic data, the optimized jolting amplitude and the optimized jolting frequency in the optimized jolting control parameters are compensated and adjusted to obtain the optimal jolting amplitude and the optimal jolting frequency as the optimal jolting control parameters.

6. The drug long-term storage device based on cold chain management according to claim 1, characterized in that: The temperature change impact analysis module is also used for: According to the optimal sloshing control parameters, the sloshing device is controlled to eliminate sloshing deposits of refrigerated transport medicines; Collecting a set of sample shaking control parameters, a set of sample shaking power, and a set of sample refrigeration temperature, and collecting a set of sample power temperature change influence parameters and a set of sample shaking temperature change influence parameters, wherein the sample power temperature change influence parameters include the influence parameters of shaking power on drug temperature, and the sample shaking temperature change influence includes the influence parameters of shaking on drug temperature; The sample sway control parameter set, the sample refrigeration temperature set and the sample sway temperature change influence parameter set are used to train the sway temperature change influence analysis branch, and the sample sway power set, the sample refrigeration temperature set and the sample power temperature change influence parameter set are used to train the power temperature change influence analysis branch; Integrate the sway temperature change impact analysis branch and the power temperature change impact analysis branch to obtain a temperature change stress analyzer; The optimal sway power of the optimal sway control parameter is obtained, and the temperature-dependent stress analyzer is used to perform temperature-dependent stress analysis on the optimal sway control parameter and the optimal sway power to obtain sway temperature-dependent stress influence parameters and power temperature-dependent stress influence parameters, and the temperature-dependent stress influence parameters are calculated.

7. The drug long-term storage device based on cold chain management according to claim 1, characterized in that: The temperature control module is also used for: Randomly selecting a first refrigeration temperature control scheme in the refrigeration temperature control scheme space of the cold chain equipment; Obtaining a first refrigerated temperature under the control of the first refrigerated temperature control scheme, and calculating a first changed drug refrigerated temperature in combination with the temperature change influencing parameter; Calculating a first temperature control adaptability according to the deviation between the first changed drug refrigeration temperature and the refrigeration temperature; Continue to optimize the refrigerated temperature control and obtain the refrigerated temperature control solution with the greatest temperature control adaptability as the optimal refrigerated temperature control solution.

8. The drug long-term storage device based on cold chain management according to claim 1, characterized in that: The shaking device is a drug shaking device.

Citation Information

Patent Citations

  • Biological product transportation management method and system

    CN114707941A

  • Cold chain temperature monitoring management method and system

    CN117273578A

  • Cold chain transportation intelligent monitoring method, system and equipment and storage medium

    CN117635009A

  • Drug refrigerated transport distribution monitoring management system

    CN117893119A

  • Zero-carbon park energy coordination control optimization method and device based on virtual power plant

    CN118244637A

Cited By

  • Method and system for predicting quality change of refrigerated medicine in cold chain transportation

    CN119648096A